A detailed history of Intrust Bank Na transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Intrust Bank Na holds 3,357 shares of VRTX stock, worth $1.59 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
3,357
Previous 3,412 1.61%
Holding current value
$1.59 Million
Previous $1.43 Million 10.31%
% of portfolio
0.17%
Previous 0.15%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$392.81 - $485.53 $21,604 - $26,704
-55 Reduced 1.61%
3,357 $1.57 Million
Q1 2024

May 09, 2024

BUY
$407.69 - $446.08 $25,276 - $27,656
62 Added 1.85%
3,412 $1.43 Million
Q4 2023

Feb 05, 2024

BUY
$343.0 - $410.68 $105,987 - $126,900
309 Added 10.16%
3,350 $1.36 Million
Q3 2023

Nov 13, 2023

BUY
$338.18 - $362.46 $9,807 - $10,511
29 Added 0.96%
3,041 $1.06 Million
Q2 2023

Aug 10, 2023

BUY
$314.42 - $351.91 $36,158 - $40,469
115 Added 3.97%
3,012 $1.06 Million
Q1 2023

May 04, 2023

BUY
$283.23 - $323.1 $90,916 - $103,715
321 Added 12.46%
2,897 $912,000
Q4 2022

Feb 10, 2023

BUY
$285.76 - $321.48 $58,580 - $65,903
205 Added 8.65%
2,576 $743,000
Q3 2022

Nov 09, 2022

BUY
$273.83 - $305.53 $55,313 - $61,717
202 Added 9.31%
2,371 $686,000
Q2 2022

Aug 16, 2022

BUY
$234.96 - $292.55 $105,732 - $131,647
450 Added 26.18%
2,169 $611,000
Q1 2022

May 10, 2022

BUY
$221.42 - $260.97 $176,693 - $208,254
798 Added 86.64%
1,719 $448,000
Q4 2021

Feb 03, 2022

BUY
$177.01 - $223.45 $163,026 - $205,797
921 New
921 $202,000
Q3 2021

Nov 04, 2021

SELL
$181.39 - $202.99 $240,160 - $268,758
-1,324 Closed
0 $0
Q2 2021

Aug 05, 2021

BUY
$187.49 - $221.1 $22,498 - $26,532
120 Added 9.97%
1,324 $267,000
Q1 2021

Jun 02, 2021

SELL
$207.02 - $241.31 $14,284 - $16,650
-69 Reduced 5.42%
1,204 $258,000
Q4 2020

Feb 10, 2021

BUY
$207.01 - $276.09 $101,020 - $134,731
488 Added 62.17%
1,273 $301,000
Q3 2020

Nov 05, 2020

BUY
$255.65 - $303.1 $200,685 - $237,933
785 New
785 $214,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $122B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Intrust Bank Na Portfolio

Follow Intrust Bank Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrust Bank Na, based on Form 13F filings with the SEC.

News

Stay updated on Intrust Bank Na with notifications on news.